삼성서울병원

Ko En

방사선종양학과 박원 교수

진료분야
비뇨의학암, 부인암, 유방암, 특수방사선치료
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 06 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2008.02 아주대학교 대학원 의학과 졸업(의학박사)
2003.02 연세대학교 대학원 의학과 졸업(의학석사)
1994.02 연세대학교 의과대학 졸업 (의학사)

경력

경력
2015.04 ~현재 삼성서울병원 방사선종양학과 교수
2013.09 ~ 2018.02 삼성서울병원 방사선종양학과 의국장
2009.03 ~ 2015.03 삼성서울병원 방사선종양학과 부교수
2009.09 ~ 2011.08 미국 해외 연수
2005.03 ~ 2009.02 삼성서울병원 방사선종양학과 조교수
2005.03 ~ 2009.02 성균관대학교 의과대학 방사선종양학과 조교수
2004.03 ~ 2005.02 삼성서울병원 방사선종양학과 임상조교수
2003.03 ~ 2004.02 삼성서울병원 방사선종양학과 임상전임강사
2002.05 ~ 2003.01 삼성서울병원 방사선종양학과 전임의
1999.02 방사선종양학과 전문의 자격 취득
1995.02 ~ 1999.02 신촌세브란스병원 방사선종양학과 레지던트 과정 수료
1994.03 ~ 1995.02 영동세브란스병원 인턴과정 수료

학회활동

학회활동
한국유방암학회 정회원
대한암학회 정회원
대한방사선종양학회 정회원
2015.10 ~ 현재 대한방사선종양학회 편집이사

수상이력

수상이력
2015.10 대한방사선종양학회 최우수 학술상
  • PLoS One. 2017 Mar 16;12(3):e0173476. doi: 10.1371/journal.pone.0173476. eCollection 2017. Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06) Joo JH11, Kim YS1, Cho BC1, Jeong CY1, Park W2, Kim HJ3, Yoon WS4, Yoon MS5, Kim JY6, Choi JH7, Choi Y8, Kim JY9.
    View PubMed
  • Int J Gynecol Cancer. 2017 Mar;27(3):507-513. doi: 10.1097/IGC.0000000000000909. Parametrial Involvement on Magnetic Resonance Imaging Has No Effect on the Survival of Early-Stage Cervical Cancer Patients Yang K11, Park W, Huh SJ, Park BK, Kim CK, Kim BG, Bae DS, Lee JW.
    View PubMed
  • Breast Cancer Res Treat. 2017 Feb;162(1):77-83. doi: 10.1007/s10549-017-4111-1. Epub 2017 Jan 12. Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02) Kim K11, Jung SY2, Shin KH3, Kim JH4, Han W5, Lee HB5, Huh SJ6, Choi DH6, Park W6, Ahn SD7, Kim SS7, Kim JH8, Suh CO9, Kim YB9, Kim IA4,10, Kim S4,11, Kim YJ1.
    View PubMed
  • Oncotarget. 2017 Jan 3;8(1):1796-1804. doi: 10.18632/oncotarget.12882. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) Kim H11, Park W2, Yu JI2, Choi DH2, Huh SJ2, Kim YJ3, Lee ES3, Lee KS3, Kang HS3, Park IH3, Shin KH4, Kim K5, Park KR5, Kim YB6, Ahn SJ7, Lee JH8, Kim JH9, Chun M10, Lee HS11, Kim JS12, Lee JY13.
    View PubMed
  • Breast Cancer Res Treat. 2017 Jan;161(1):95-102. doi: 10.1007/s10549-016-4034-2. Epub 2016 Oct 25. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer Kim H11, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.
    View PubMed
  • J Gynecol Oncol. 2016 Nov;27(6):e58. doi: 10.3802/jgo.2016.27.e58. Epub 2016 Jul 11. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08) Cha J11, Kim YS2, Park W3, Kim HJ4, Kim JY5, Kim JH6, Kim J7, Yoon WS8, Kim JW9, Kim YB10.
    View PubMed
  • Eur J Surg Oncol. 2016 Oct;42(10):1497-505. doi: 10.1016/j.ejso.2016.07.003. Epub 2016 Jul 14. Impact of paraaortic lymphadenectomy for endometrial cancer with positive pelvic lymph nodes: A Korean Radiation Oncology Group study (KROG 13-17) Yoon MS11, Park W2, Huh SJ3, Kim HJ4, Kim YS5, Kim YB6, Kim JY7, Lee JH8, Kim HJ9, Cha J10, Kim JH11, Kim J12, Yoon WS13, Choi JH14, Chun M15, Choi Y16, Chang SK17, Lee KK18, Kim M19, Jeong JU1, Nam TK20.
    View PubMed
  • J Breast Cancer. 2016 Sep;19(3):275-282. Epub 2016 Sep 23. Radiation Pneumonitis in Association with Internal Mammary Node Irradiation in Breast Cancer Patients: An Ancillary Result from the KROG 08-06 Study Choi J11, Kim YB1, Shin KH2, Ahn SJ3, Lee HS4, Park W5, Kim SS6, Kim JH7, Lee KC8, Kim DW9, Suh HS10, Park KR10, Shin HS11, Suh CO1.
    View PubMed
  • Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy Yu JI11, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.
    View PubMed
  • J Gynecol Oncol. 2016 Jul;27(4):e33. doi: 10.3802/jgo.2016.27.e33. Epub 2016 Feb 3. Current status of brachytherapy in Korea: a national survey of radiation oncologists Kim H11, Kim JY2, Kim J3, Park W4, Kim YS5, Kim HJ6, Kim YB7.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):955-61. doi: 10.4143/crt.2015.191. Epub 2016 Jan 19. Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer Kim H11, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):1074-83. doi: 10.4143/crt.2015.356. Epub 2015 Oct 29. Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma Yoon MS11, Huh SJ2, Kim HJ3, Kim YS4, Kim YB5, Kim JY6, Lee JH7, Kim HJ8, Cha J9, Kim JH10, Kim J11, Yoon WS12, Choi JH13, Chun M14, Choi Y15, Lee KK16, Kim M17, Jeong JU1, Chang SK18, Park W2.
    View PubMed
  • Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11. Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Medicine (Baltimore). 2016 Jun;95(25):e3895. doi: 10.1097/MD.0000000000003895. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session Oh D11, Huh SJ, Park W, Ju SG, Nam H, Lee JE.
    View PubMed
  • J Breast Cancer. 2016 Jun;19(2):169-75. doi: 10.4048/jbc.2016.19.2.169. Epub 2016 Jun 24. Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes Kim SW11, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.
    View PubMed
  • J Gynecol Oncol. 2016 Mar;27(2):e17. doi: 10.3802/jgo.2016.27.e17. Definitive treatment of primary vaginal cancer with radiotherapy: multi-institutional retrospective study of the Korean Radiation Oncology Group (KROG 12-09) Chang JH11, Jang WI2, Kim YB3, Kim JH4, Kim YS5, Kim YS1, Park W6, Kim J7, Yoon WS8, Kim JY9, Kim HJ10.
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):297-303. doi: 10.4143/crt.2014.333. Epub 2015 Mar 13. Can Anorectal Manometry Findings Predict Subsequent Late Gastrointestinal Radiation Toxicity in Prostate Cancer Patients Choi Y11, Park W2, Rhee PL3.
    View PubMed
  • Tumori. 2016 Jan-Feb;102(1):114-21. doi: 10.5301/tj.5000439. Epub 2015 Oct 7. Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery Kim TG11, Park W2, Choi DH2, Park HC2, Kim SH3, Cho YB4, Yun SH4, Kim HC4, Lee WY4, Lee J5, Park JO5, Park YS5, Lim HY5, Kang WK5, Chun HK6.
    View PubMed
  • Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Technol Cancer Res Treat. 2015 Oct;14(5):525-9. doi: 10.7785/tcrt.2012.500415. Epub 2014 Nov 24. Incidental Findings on Simulation CT Images for Adjuvant Radiotherapy in Breast Cancer Patients Park JS11, Choi DH2, Huh SJ1, Park W1, Nam SJ3, Lee JE3, Kil WH3, Lee KS4.
    View PubMed
  • Breast. 2015 Oct;24(5):637-41. doi: 10.1016/j.breast.2015.07.016. Epub 2015 Aug 14. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy Noh JM11, Kim KH2, Park W3, Suh CO4, Huh SJ1, Choi DH1, Keum KC2, Kim YB2.
    View PubMed
  • Clin Breast Cancer. 2015 Oct;15(5):353-61.e1-2. doi: 10.1016/j.clbc.2015.01.008. Epub 2015 Feb 7. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06) Yu JI11, Choi DH2, Huh SJ1, Cho EY3, Kim K4, Chie EK4, Ha SW4, Park IA5, Ahn SJ6, Lee JS7, Shin KH8, Kwon Y8, Kim YB9, Suh CO9, Koo JS10, Kim JH11, Jeong BG12, Kim IA13, Lee JH14, Park W1.
    View PubMed
  • J Breast Cancer. 2015 Sep;18(3):285-90. doi: 10.4048/jbc.2015.18.3.285. Epub 2015 Sep 24. Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast Park JS11, Choi DH1, Huh SJ1, Park W1, Kim YI2, Nam SJ3, Lee JE3, Kil WH3.
    View PubMed
  • Gynecol Oncol. 2015 Sep;138(3):519-25. doi: 10.1016/j.ygyno.2015.06.030. Epub 2015 Jun 24. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17) Yoon MS11, Park W2, Huh SJ3, Kim HJ4, Kim YS5, Kim YB6, Kim JY7, Lee JH8, Kim HJ9, Cha J10, Kim JH11, Kim J12, Yoon WS13, Choi JH14, Chun M15, Choi Y16, Chang SK17, Lee KK18, Kim M19.
    View PubMed
  • Fam Cancer. 2015 Sep;14(3):365-71. doi: 10.1007/s10689-015-9789-9. Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation Kim H11, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.
    View PubMed
  • Breast Cancer Res Treat. 2015 Aug;152(3):589-99. doi: 10.1007/s10549-015-3505-1. Epub 2015 Jul 23. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy Kim KH11, Noh JM, Kim YB, Chang JS, Keum KC, Huh SJ, Choi DH, Park W, Suh CO.
    View PubMed
  • Int J Gynecol Cancer. 2015 May;25(4):688-93. doi: 10.1097/IGC.0000000000000404. Correlation Between Location of Transposed Ovary and Function in Cervical Cancer Patients Who Underwent Radical Hysterectomy Yoon A11, Lee YY, Park W, Huh SJ, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Clin Breast Cancer. 2015 Apr;15(2):e105-15. doi: 10.1016/j.clbc.2014.10.002. Epub 2014 Oct 12. Unique Characteristics and Failure Patterns of Metaplastic Breast Cancer in Contrast to Invasive Ductal Carcinoma: A Retrospective Multicenter Case-Control Study (KROG 13-07) Yu JI11, Choi DH2, Huh SJ1, Ahn SJ3, Lee JS4, Shin KH5, Kwon Y5, Kim YB6, Suh CO6, Kim JH7, Cho J8, Kim IA9, Lee JH10, Park W1.
    View PubMed
  • Ann Surg Oncol. 2015 Apr;22(4):1308-14. doi: 10.1245/s10434-014-4146-z. Epub 2014 Oct 16. Salvage Radiation Therapy for Isolated Local Recurrence of Extrahepatic Cholangiocarcinoma After Radical Surgery: A Retrospective Study Kim SW11, Lim do H, Park HC, Park W, Park JO, Park YS.
    View PubMed
  • J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27. Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer Yu JI11, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):419-26. doi: 10.1016/j.ijrobp.2014.10.022. Dummy Run of Quality Assurance Program in a Phase 3 Randomized Trial Investigating the Role of Internal Mammary Lymph Node Irradiation in Breast Cancer Patients: Korean Radiation Oncology Group 08-06 Study Chung Y11, Kim JW2, Shin KH3, Kim SS4, Ahn SJ5, Park W6, Lee HS7, Kim DW8, Lee KC9, Suh HS10, Kim JH11, Shin HS12, Kim YB13, Suh CO1.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):68-74. doi: 10.3802/jgo.2015.26.1.68. Asian Society of Gynecologic Oncology International Workshop 2014 Park JY11, Ngan HY2, Park W3, Cao Z4, Wu X5, Ju W6, Chung HH7, Chang SJ8, Park SY9, Ryu SY10, Kim JH11, Cho CH12, Lee KH13, Lee JW14, Kumarasamy S15, Kim JW7, Wilailak S16, Kim BG14, Kim DY1, Konishi I17, Lee JK18, Wang KL19, Nam JH20.
    View PubMed
  • Int J Urol. 2015 Jan;22(1):82-7. doi: 10.1111/iju.12604. Epub 2014 Sep 10. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery Chang JH11, Park W, Park JS, Pyo H, Huh SJ, Choi HY, Lee HM, Jeon SS, Seo SI.
    View PubMed
  • Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23. Excision alone for small size ductal carcinoma in situ of the breast Kim H11, Noh JM2, Choi DH3, Lee J4, Nam SJ5, Lee JE5, Park W4, Huh SJ4.
    View PubMed
  • Colorectal Dis. 2014 Aug;16(8):O257-63. doi: 10.1111/codi.12554. The adequacy of the distal resection margin after preoperative chemoradiotherapy for rectal cancer 1,chemoradiotherapy for rectal cancer.
    View PubMed
  • Eur Radiol. 2014 Jul;24(7):1514-20. doi: 10.1007/s00330-014-3167-0. Epub 2014 Apr 25. Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience Kim CK11, Park SY, Park BK, Park W, Huh SJ.
    View PubMed
  • Breast Cancer Res Treat. 2014 Jul;146(2):341-5. doi: 10.1007/s10549-014-3025-4. Epub 2014 Jun 18. Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04) Kim JH11, Choi DH, Park W, Ahn SD, Kim SS, Ha SW, Kim K, Kim YB, Yea JW, Kang MK, Shin KH, Kim DW, Lee JH, Suh CO.
    View PubMed
  • Cancer Res Treat. 2014 Jul;46(3):243-9. doi: 10.4143/crt.2014.46.3.243. Epub 2014 Jul 15. Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically 12 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06) Noh JM11, Park W, Kim JS, Koom WS, Kim JH, Choi DH, Park HC.
    View PubMed
  • Radiother Oncol. 2014 Jun;111(3):437-41. doi: 10.1016/j.radonc.2014.03.025. Epub 2014 Jun 5. A nomogram predicting the risks of distant metastasis following postoperative radiotherapy for uterine cervical carcinoma: A Korean radiation oncology group study (KROG 12-08) Je HU11, Han S1, Kim YS2, Nam JH1, Kim HJ3, Kim JW3, Park W4, Bae DS4, Kim JH5, Shin SJ5, Kim J6, Lee KH6, Yoon MS7, Kim SM7, Kim JY8, Yoon WS9, Lee NW9, Choi JH10, Park SY11, Kim JY11.
    View PubMed
  • J Radiat Res. 2014 May;55(3):553-8. doi: 10.1093/jrr/rrt141. Epub 2014 Jan 1. Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection Noh JM11, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • Cancer Res Treat. 2014 Apr;46(2):148-57. doi: 10.4143/crt.2014.46.2.148. Epub 2014 Apr 22. Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy Kim H11, Chie EK2, Ahn YC3, Kim K2, Park W3, Yoon WS4, Huh SJ3, Ha SW2.
    View PubMed
  • Cancer Genet. 2014 Apr;207(4):160-3. doi: 10.1016/j.cancergen.2014.04.002. Epub 2014 Apr 12. Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population Noh JM11, Choi DH2, Baek H3, Kim MJ4, Park H1, Huh SJ1, Park W1, Nam SJ5, Lee JE5, Kil WH5, Haffty BG6.
    View PubMed
  • Cancer?Res Treat.?2014 Apr;46(2):158-64. doi: 10.4143/crt.2014.46.2.158. Epub 2014 Apr 22. Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Lee NK11,?Kim DY2,?Kim SY3,?Oh JH3,?Park W4,?Choi DH4,?Nam TK5,?Lee KJ6.
    View PubMed
  • Gynecol Oncol. 2014 Mar;132(3):618-23. doi: 10.1016/j.ygyno.2014.01.043. Epub 2014 Jan 31. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: A multicenter retrospective study (KROG 13-10) Noh JM11, Park W2, Kim YS3, Kim JY4, Kim HJ5, Kim J6, Kim JH7, Yoon MS8, Choi JH9, Yoon WS10, Kim JY11, Huh SJ1.
    View PubMed
  • Br J Cancer. 2014 Mar 18;110(6):1420-6. doi: 10.1038/bjc.2014.26. Epub 2014 Jan 30. Is elective nodal irradiation beneficial in patients with pathologically negative lymph nodes after neoadjuvant chemotherapy and breast-conserving surgery for clinical stage II-III breast cancer A multicentre retrospective study (KROG 12-05) Noh JM11, Park W1, Suh CO2, Keum KC2, Kim YB2, Shin KH3, Kim K4, Chie EK4, Ha SW4, Kim SS5, Ahn SD5, Shin HS6, Kim JH7, Lee HS8, Lee NK9, Huh SJ1, Choi DH1.
    View PubMed
  • Radiother Oncol. 2014 Feb;110(2):240-4. doi: 10.1016/j.radonc.2014.01.001. Epub 2014 Jan 28. Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy Park JS11, Park W2, Pyo HR1, Park BK3, Park SY3, Choi HY4, Lee HM4, Jeon SS4, Seo SI4, Jeong BC4, Jeon HG4.
    View PubMed
  • Int J Colorectal Dis. 2014 Feb;29(2):193-200. doi: 10.1007/s00384-013-1797-3. Epub 2013 Dec 10. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients Kim TG11, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK.
    View PubMed
  • Int J Radiat Biol. 2014 Jan;90(1):90-4. doi: 10.3109/09553002.2013.835504. Epub 2013 Sep 19. Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations Park H11, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):65-72. doi: 10.1016/j.ijrobp.2013.09.021. Epub 2013 Oct 22. The Role of Postmastectomy Radiation Therapy After Neoadjuvant Chemotherapy in Clinical Stage II-III Breast Cancer Patients With pN0: A Multicenter, Retrospective Study (KR0G 12-05) Shim SJ11, Park W2, Huh SJ3, Choi DH3, Shin KH4, Lee NK5, Suh CO6, Keum KC6, Kim YB6, Ahn SD7, Kim SS7, Ha SW8, Chie EK8, Kim K8, Shin HS9, Kim JH10, Lee HS11.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):659-64. doi: 10.1016/j.ijrobp.2013.07.020. Individualized Prediction of Overall Survival After Postoperative Radiation Therapy in Patients With Early-Stage Cervical Cancer: A Korean Radiation Oncology Group Study (KROG 13-03) Lee HJ11, Han S, Kim YS, Nam JH, Kim HJ, Kim JW, Park W, Kim BG, Kim JH, Cha SD, Kim J, Lee KH, Yoon MS, Kim SM, Kim JY, Yoon WS, Lee NW, Choi JH, Park SY, Kim JY.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):867-72. doi: 10.1016/j.ijrobp.2013.02.037. Epub 2013 Jun 6. Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 12-Year Follow-up Chang JS11, Park W, Kim YB, Lee IJ, Keum KC, Lee CG, Choi DH, Suh CO, Huh SJ.
    View PubMed
  • Oncology. 2013;85(1):14-20. doi: 10.1159/000352002. Epub 2013 Jun 21. Prophylactic Supraclavicular Radiotherapy after Surgery in High-Risk N1 Breast Cancer Yu JI11, Park W, Shin KH, Lee NK, Choi DH, Huh SJ.
    View PubMed
  • J Breast Cancer. 2012 Sep;15(3):329-36. doi: 10.4048/jbc.2012.15.3.329. Epub 2012 Sep 28. Radiation Treatment in Pathologic N0-N1 Patients Treated with Neoadjuvant Chemotherapy Followed by Surgery for Locally Advanced Breast Cancer Bae SH11, Park W, Huh SJ, Choi DH, Nam SJ, Im YH, Ahn JS.
    View PubMed
  • J Breast Cancer. 2012 Mar;15(1):105-10. doi: 10.4048/jbc.2012.15.1.105. Epub 2012 Mar 28. Dose-Volume Analysis of Lung and Heart according to Respiration in Breast Cancer Patients Treated with Breast Conserving Surgery Shim JG11, Kim JK, Park W, Seo JM, Hong CS, Song KW, Lim CH, Jung HR, Kim CH.
    View PubMed
  • Indian J Exp Biol. 2012 Mar;50(3):195-200. Protective effect of triphala on radiation induced acute intestinal mucosal damage in Sprague Dawley rats Yoon WS11, Kim CY, Yang DS, Park YJ, Park W, Ahn YC, Kim SH, Kwon GY.
    View PubMed
  • Radiat Oncol. 2011 May 21;6:52. doi: 10.1186/1748-717X-6-52. Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer Bae SH11, Park W, Choi DH, Nam H, Kang WK, Park YS, Park JO, Chun HK, Lee WY, Yun SH, Kim HC.
    View PubMed
  • Onkologie. 2011;34(1-2):36-41. doi: 10.1159/000323382. Epub 2011 Jan 24. Which Patients Benefit from Preoperative Chemoradiotherapy for Intermediate Staged Rectal Cancer Yoon WS11, Park W, Choi DH, Ahn YC, Chun HK, Lee WY, Yun SH, Kim HC, Cho YB, Kang WK, Park YS, Park JO, Lim HY, Park SH, Lee J.
    View PubMed
  • Ann Surg.?2010 Dec;252(6):998-1004. doi: 10.1097/SLA.0b013e3181f3f1b1. Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01) Yeo SG11,?Kim DY,?Kim TH,?Chang HJ,?Oh JH,?Park W,?Choi DH,?Nam H,?Kim JS,?Cho MJ,?Kim JH,?Park JH,?Kang MK,?Koom WS,?Kim JS,?Nam TK,?Chie EK,?Kim JS,?Lee KJ.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1135-41. doi: 10.1016/j.ijrobp.2009.09.037. Epub 2010 Mar 16. DETERMINING WHICH PATIENTS REQUIRE IRRADIATION OF THE SUPRACLAVICULAR NODAL AREA AFTER SURGERY FOR N1 BREAST CANCER Yu JI11, Park W, Huh SJ, Choi DH, Lim YH, Ahn JS, Yang JH, Nam SJ.
    View PubMed
  • Tumori. 2010 Jul-Aug;96(4):568-76. Importance of the circumferential extent of tumors and clinical lymph node status as prognostic factors after preoperative chemoradiotherapy and surgery in patients with rectal cancer Yoon WS11, Park W, Choi DH, Ahn YC, Chun HK, Lee WY, Yun SH, Kang WK, Lim HY, Park YS.
    View PubMed
  • Radiother Oncol. 2010 Jun;95(3):359-64. doi: 10.1016/j.radonc.2010.01.007. Epub 2010 Feb 12. Prognostic significance of CD24 protein expression in patients treated with adjuvant radiotherapy after radical hysterectomy for cervical squamous cell carcinoma Sung CO11, Park W, Choi YL, Ahn G, Song SY, Huh SJ, Bae DS, Kim BG, Lee JH.
    View PubMed
  • J Gynecol Oncol. 2009 Dec;20(4):215-20. doi: 10.3802/jgo.2009.20.4.215. Epub 2009 Dec 28. Correlation between tumor volume response to radiotherapy and expression of biological markers in patients with cervical squamous cell carcinoma Noh JM11, Park W, Huh SJ, Cho EY, Choi YL, Lee JH, Bae DS.
    View PubMed
  • J Korean Med Sci. 2009 Dec;24(6):1170-6. doi: 10.3346/jkms.2009.24.6.1170. Epub 2009 Nov 9. The Effect of Cyclooxygenase-2 Expression on Tumor Volume Response in Patients Treated with Radiotherapy for Uterine Cervical Cancer Kang MK11, Park W, Choi YL, Cho EY, Ahn G, Nam H, Huh SJ, Ahn YC, Lim do H, Oh DR, Bae DS, Kim BG.
    View PubMed
  • Int J Dermatol. 2009 Jul;48(7):784-6. doi: 10.1111/j.1365-4632.2009.04029.x. Scleredema adultorum of Buschke associated with a carcinoid tumor Yu JI1, Park W, Lee KK, Park W.
    View PubMed
  • J Exp Clin Cancer Res. 2008 Nov 11;27:66. doi: 10.1186/1756-9966-27-66. Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2 Park W11, Oh YT, Han JH, Pyo H.
    View PubMed
  • Ann Nucl Med. 2008 Oct;22(8):685-91. doi: 10.1007/s12149-008-0158-8. Epub 2008 Nov 4. The implication of hot spots on bone scans within the irradiated field of breast cancer patients treated with mastectomy followed by radiotherapy Park W11, Huh SJ, Yang JH, Nam SJ, Kim JH, Choi JY, Woo SY, Kim HY, Noh JM, Ryu JI.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1150-6. Epub 2007 Aug 9. Role of CD24 protein in predicting metastatic potential of uterine cervical squamous cell carcinoma in patients treated with radiotherapy Kwon GY11, Ha H, Ahn G, Park SY, Huh SJ, Park W.
    View PubMed
  • Yonsei Med J. 2007 Oct 31;48(5):827-32. Anal canal carcinoma: Experience from a single Korean institution Lee WS11, Chun HK, Lee WY, Yun SH, Yun H, Cho YB, Kang WK, Park YS, Huh SJ, Ahn YC, Park W.
    View PubMed
  • Gynecol Oncol. 2005 Dec;99(3):645-51. Epub 2005 Sep 8. Variation of small bowel sparing with small bowel displacement system according to the physiological status of the bladder during radiotherapy for cervical cancer Park W11, Huh SJ, Lee JE, Han Y, Shin E, Ahn YC, Lim DH.
    View PubMed
  • Cancer.?2005 Jun 1;103(11):2419-26. Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma Kim DY11,?Park W,?Lim DH,?Lee JH,?Yoo BC,?Paik SW,?Kho KC,?Kim TH,?Ahn YC,?Huh SJ.
    View PubMed
  • Jpn J Clin Oncol. 2005 May;35(5):260-4. Epub 2005 May 10. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer Park W11, Park YJ, Huh SJ, Kim BG, Bae DS, Lee J, Kim BH, Choi JY, Ahn YC, Lim DH.
    View PubMed
  • Int J Radiat Oncol Biol Phys.?2005 Mar 15;61(4):1143-50. Local radiotherapy for patients with unresectable hepatocellular carcinoma Park W11,?Lim DH,?Paik SW,?Koh KC,?Choi MS,?Park CK,?Yoo BC,?Lee JE,?Kang MK,?Park YJ,?Nam HR,?Ahn YC,?Huh SJ.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1480-6. Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma Park W11, Chang SK, Yang WI, Ko YH, Huh SJ, Ahn YC, Suh CO.
    View PubMed
  • Radiother Oncol. 2004 Apr;71(1):73-9. Interfractional variation in position of the uterus during radical radiotherapy for cervical cancer Huh SJ11, Park W, Han Y.
    View PubMed

해당하는 결과가 없습니다.